Case Report | Open Access
ST Segment Elevation Is Not Always Myocardial Infarction: A Case of Focal Myopericarditis
Protocols exist on how to manage STEMI patients, with well-established timelines. There are times when patients present with chest pain, ST segment elevation, and biomarker elevation that are not due to coronary artery disease. These conditions usually present with normal coronary angiography. We present a case that was clinically indistinguishable from STEMI and that was diagnosed with focal myopericarditis on cardiac MRI.
Typical chest pain with elevated ST segment elevation on electrocardiogram (EKG) is a medical emergency, with well-drilled protocols and timeline targets . There are times when the ST elevation is not due to coronary obstruction but a mimic. Inflammation associated with myopericarditis can produce chest pain and EKG changes that may be clinically indistinguishable from a coronary event. Myalgia, fatigue, pleuritic chest pain, and fever are common presentations associated with viral illness, but the absence of this history does not preclude post viral myopericarditis. Typical cardiac chest pain and elevated cardiac enzymes can be present in acute coronary syndrome (ACS) as well as in myopericarditis, especially its focal form. Few case reports have been published on this rare and important mimic [2, 3]. We present a case of a young male who presented with indistinguishable features and was treated as STEMI, later to turn out as focal myocarditis.
2. Case Presentation
A previously healthy 33-year-old white male presented with sudden onset substernal chest pain that started while exercising on a treadmill one hour before. He described a left sided sharp, nonradiating pain that persisted till he presented to the ER. He had associated nausea, diaphoresis, and shortness of breath. Nothing made it better. He denied heartburn, vomiting, cough, fever, and recent travel. He had no personal or family history of heart disease. On physical examination, he was a young athletic male with normal vital signs, and he appeared in distress from the pain. His cardiovascular examination was normal with no murmurs or pericardial rubs. He had an elevated troponin I at 21.9 ng/ml and an EKG ST segment elevation in the inferior leads (Figure 1). All other baseline laboratory tests were within normal limits. A STEMI alert was placed, and patients had an emergent left cardiac catheterization that reported normal coronary anatomy with no obstructing coronary stenosis (Figures 2 and 3). A left ventriculogram was also normal. He was started on a heparin drip and transferred to the coronary care unit. A plain chest X-ray did not reveal any pulmonary lesions or consolidation, and a chest CT angiogram ruled out pulmonary embolism. A transthoracic echocardiogram done reported a normal left ventricular ejection fraction (EF 50–55%) and a slight enlargement of the right ventricle without any wall motion abnormalities. Two days after presentation, the patient still reported continued chest pain and had an episode of nonsustained ventricular tachycardia (NSVT). At this point, a cardiac MRI was done (Figures 4–7) that demonstrated epicardial and midmyocardial enhancement in the inferior wall, sparing of the subendocardial region, and overlying focal pericardial enhancement, consistent with EKG changes. He was started on indomethacin; his symptoms improved in the following 5 days, and he was discharged.
The presentation of myopericarditis is widely variable from asymptomatic to focal or diffuse myopericarditis, congestive failure, and even sudden cardiac death. Diffuse myopericarditis has well variable presentation and EKG changes, reflecting the degree of myonecrosis. Certain changes on EKG are associated with myocarditis rather than pure pericarditis, such as ST segment elevations and occurrence of arrhythmias as was evident in our patient . Focal myopericarditis on the other hand may have EKG findings indistinguishable from STEMI as is seen in our case. Chest pain with unusual cardiac risk profile and normal coronary angiography should raise suspicion of focal myopericarditis. The gold standard for diagnosis of myocarditis is endomyocardial biopsy, which has variable sensitivity of up to 64% . The noninvasive cardiac MRI is increasingly being used to make the diagnosis of myocarditis and is associated with sensitivity of up to 90% in one study [6, 7]. The pattern of myocarditis on MRI includes focal or global calculated myocardial early enhancement ration greater than 4.5 compared to skeletal muscles, focal or global intense T2 signal indicative of edema, or late gadolinium enhancement with nonregional ischemic distribution. These often involve epicardium towards myocardium, typically sparing the subendocardium, while myocardial infarction displays a pattern of enhancement involving the subendocardium [8–10]. Using the Lake Louise Consensus criteria , our patients’ findings were consistent with myocarditis by displaying early gadolinium enhancement ratios, regional T2 signal edema, and myocardial late gadolinium enhancement. It is arguable that the region of cardiac MRI findings could have been consistent with a spontaneously reperfused coronary artery disease, and this theory could not be proven in our case. Our patient had no traditional risk factors for coronary artery disease, though the sudden onset of symptoms pointed to ACS and the coronary angiograms was clear of atherosclerosis.
Similar presentations to this patient that were ruled out include Takotsubo cardiomyopathy as the ventriculogram was normal during cardiac catheterization. The coronary anatomy was normal, and thus both coronary artery disease and spontaneous coronary dissection were ruled out. Our patient had no eosinophilia on peripheral blood testing; hence, hyper eosinophilic myocarditis and hypersensitivity myocarditis were also ruled out.
Focal myopericarditis may present with typical chest pain, ST segment elevation on EKG, and biomarker elevation that may be indistinguishable from STEMI. Unusual cardiac risk profile, in absence of traditional cardiac risk factors, should raise suspicion of alternative diagnosis. Cardiac MRI is useful in distinguishing myopericarditis from MI.
Conflicts of Interest
The authors declare that there are no conflicts of interest regarding the publication of this paper.
- G. N. Levine, E. R. Bates, J. C. Blankenship et al., “2015 ACC/AHA/SCAI focused update on primary percutaneous coronary intervention for patients with ST-elevation myocardial infarction: an update of the 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention and the 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction,” Journal of the American College of Cardiology, vol. 67, no. 10, pp. 1235–1250, 2016.
- Y. Nozari, M. Tajdini, M. Mehrani, and R. Ghaderpanah, “Focal myopericarditis as a rare but important differential diagnosis of myocardial infarction; a case series,” Emergency, vol. 4, no. 3, pp. 159–162, 2016, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4902212/.
- J. M. Testani, D. M. Kolansky, H. Litt, and E. P. Gerstenfeld, “Focal myocarditis mimicking acute ST-elevation myocardial infarction,” Texas Heart Institute Journal, vol. 33, no. 2, pp. 256–259, 2006.
- M. Imazio, E. Cecchi, B. Demichelis et al., “Myopericarditis versus viral or idiopathic acute pericarditis,” Heart, vol. 94, no. 4, pp. 498–501, 2008.
- L. H. Chow, S. J. Radio, T. D. Sears, and B. M. Mcmanus, “Insensitivity of right ventricular endomyocardial biopsy in the diagnosis of myocarditis,” Journal of the American College of Cardiology, vol. 14, no. 4, pp. 915–920, 1989.
- J. P. Laissy, B. Messin, O. Varenne et al., “MRI of acute myocarditis: a comprehensive approach based on various imaging sequences,” Chest, vol. 122, no. 5, pp. 1638–1648, 2002.
- H. Mahrholdt, C. Goedecke, A. Wagner et al., “Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology,” Circulation, vol. 109, no. 10, pp. 1250–1258, 2004.
- H. Mahrholdt, A. Wagner, R. M. Judd, U. Sechtem, and R. J. Kim, “Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies,” European Heart Journal, vol. 26, no. 15, pp. 1461–1474, 2005.
- G. Gahide, D. Bertrand, F. Roubille et al., “MR delayed enhancement imaging findings in suspected acute myocarditis,” European Radiology, vol. 20, no. 1, pp. 65–72, 2010.
- M. G. Friedrich, U. Sechtem, J. Schulz-Menger et al., “Cardiovascular magnetic resonance in myocarditis: a JACC white paper,” Journal of the American College of Cardiology, vol. 53, no. 17, pp. 1475–1487, 2009.
Copyright © 2017 Cyrus M. Munguti et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.